News | ECG | February 16, 2021

New ECG System Eliminated Wire Leads to Simplify Standard 12-Lead ECG 

Company says it reduces patient contact during the COVID-19 pandemic and is the world’s first 12-lead ECG service for home use

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.


February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG home test, to help reduce the risk of exposure to COVID-19 by bringing ECG tests to patients’ homes. The 12-lead ECG (EKG) with PCA 500 and makes it available for use by both healthcare professionals and patients. 

In response to the surge of needs in the COVID-19 pandemic, the company offers Xpress ECG service, which makes ECG tests accessible and affordable, while decreasing the risk of exposure to potential infections. The physicians can now simply order Xpress ECG tests online and the ECG kits will be shipped to the patients in 1 to 3 business days.

The ECG tests are performed using PCA 500, a complete 12-lead ECG platform that includes a super-compact recorder, prepositioned electrode strip, mobile app, HIPAA-compliant cloud and preliminary interpretation. 

“This new exclusive service offers patients the ability to monitor their own heart health, allows healthcare providers to continue providing quality of care while maximizing revenue, and minimizing cost and risks for the healthcare system. Xpress ECG enables millions of patients with heart diseases to manage their health from the comfort of their homes,” said Ruey-Kang Chang, M.D., CEO of QT Medical Inc.

With the new CPT codes (e.g. 99457), an ECG test done by patients at home can be reimbursed 3 times higher than an ECG test done in the doctor’s office. When the doctor orders an Xpress ECG test, a kit including a PCA 500 recorder, an electrode strip, and a postage-paid return envelope will be shipped to the patients. QT Medical had previously conducted a clinical trial, which showed minimal or no training is needed to use PCA 500. All ECGs are automatically transmitted to the cloud, and a preliminary computer interpretation is instantly available. Through the cloud, physicians can review the results from anywhere to make informed decisions.

Unlike dozens of single lead ECG devices on the market, PCA 500 is hospital grade 12-lead ECG, which is medical standard for diagnosing a wide variety of heart diseases such as heart attacks, long QT syndrome, myocarditis, adverse effects of medications, cardiomyopathy, etc. Using Xpress ECG, healthcare providers can minimize the risk of infection by not sending patients to labs or hospitals for ECG tests. Telehealth patients who need an ECG test will be able to get a full 12-lead ECG without leaving their homes.

Xpress ECG is a medical standard 12-lead ECG test, using PCA 500, ordered by healthcare providers. Patients should consult their physicians to decide if PCA 500 is right for them.

QT Medical is a medtech company with a focus on high quality 12-lead diagnostic ECG for use by healthcare professionals and patients. Cleared by the FDA in 2018 and CE marked in 2020, PCA 500 is the world’s most compact 12-lead ECG system. With its simplicity, ease of use, mobile technology and cloud management, PCA 500 brings hospital-grade ECG to homes, and enables doctors to make informed decisions anywhere, anytime. 

For more information: www.qtmedical.com


Related Content

News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Subscribe Now